A multicenter phase II trial of tumor treating fields plus chemotherapy for first-line treatment of gastric adenocarcinoma

被引：0
|
作者：
Li, Jin
Yeo, Winnie
Lam, Ka-On
机构：
[1] Fudan Univ, Shanghai Med Coll, Dept Oncol, Dept Med Oncol,Shanghai Canc Ctr, Shanghai, Peoples R China
[2] Chinese Univ Hong Kong, Hong Kong, Peoples R China
[3] Univ Hong Kong, Shenzhen Hosp, Shenzhen, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS474
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A phase Ⅱ trial of oxaliplatin plus S-1 as a first-line chemotherapy for patients with advanced gastric cancer
    YANG Lin
    SONG Yan
    ZHOU Ai-ping
    QIN Qiong
    CHI Yihebali
    HUANG Jing
    WANG Jin-wan
    中华医学杂志（英文版）, 2013, 126 (18) : 3470 - 3474
  • [32] A Phase II Study of Capecitabine plus Oxaliplatin as First-Line Chemotherapy in Elderly Patients with Advanced Gastric Cancer
    Xiang, Xiao Jun
    Zhang, Ling
    Qiu, Feng
    Yu, Feng
    Zhan, Zheng Yu
    Feng, Miao
    Yan, Jun
    Zhao, Jian Guo
    Xiong, Jian Ping
    CHEMOTHERAPY, 2012, 58 (01) : 1 - 7
  • [33] ITALIAN MULTICENTER PHASE II TRIAL USING FOTEMUSTINE PLUS BEVACIZUMAB AS FIRST-LINE THERAPY IN METASTATIC MELANOMA
    Canova, S.
    Cortinovis, D. L.
    Del Vecchio, M.
    Anichini, A.
    Pimpinelli, N.
    Sertoli, M. R.
    Mortarini, R.
    De Min, C.
    Bajetta, E.
    ANNALS OF ONCOLOGY, 2008, 19 : 245 - 245
  • [34] A multicenter phase I/II trial of induction chemotherapy followed by camrelizumab, apatinib, plus chemotherapy as first-line treatment for extensive-stage small-cell lung cancer
    Zhou, Chengzhi
    Liu, Ming
    Qiu, Guihuan
    Xie, Xiaohong
    Lin, Xinqing
    Guan, Wenhui
    Xie, Zhanhong
    Zhang, Jiexia
    Qin, Yinyin
    Du, Haijian
    Chen, Xin
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [35] Tislelizumab Plus Chemotherapy as First-line Treatment for Advanced Esophageal Squamous Cell Carcinoma and Gastric/Gastroesophageal Junction Adenocarcinoma
    Xu, Jianming
    Bai, Yuxian
    Xu, Nong
    Li, Enxiao
    Wang, Buhai
    Wang, Jin
    Li, Xiang
    Wang, Xin
    Yuan, Xianglin
    CLINICAL CANCER RESEARCH, 2020, 26 (17) : 4542 - 4550
  • [36] Biweekly Oxaliplatin and Irinotecan Chemotherapy in Advanced Gastric Cancer. A First-line Multicenter Phase II Trial of the Arbeitsgemeinschaft Medikamentose Tumortherapie (AGMT)
    Woell, E.
    Kuehr, T.
    Eisterer, W.
    Gattringer, K.
    Greil, R.
    Zabernigg, A.
    Hilbe, W.
    Thaler, J.
    ANTICANCER RESEARCH, 2008, 28 (5B) : 2901 - 2905
  • [37] A phase II trial of first-line FOLFIRINOX for patients with advanced gastroesophageal adenocarcinoma
    Park, Haeseong
    Wang-Gillam, Andrea
    Suresh, Rama
    Rigden, Caron E.
    Amin, Manik A.
    Tan, Benjamin R.
    Pedersen, Katrina
    Lim, Kian-Huat
    Trikalinos, Nikolaos
    Navo, Katherine
    Morton, Ashley
    Schrumpf, Lindsey
    Marquez, Samantha
    Trinkaus, Kathryn
    Lockhart, A. Craig
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [38] Toripalimab Plus Bevacizumab as First-line Treatment for Advanced Hepatocellular Carcinoma: A Prospective, Multicenter, Single-Arm, Phase II Trial
    Chen, Yajin
    Du, Chengyou
    Shen, Shunli
    Zhang, Wu
    Shan, Yunfeng
    Lyu, Ang
    Wu, Jianhui
    Shang, Changzhen
    Luo, Xuan
    Wei, Jinxing
    Xiao, Heng
    Qiu, Jianguo
    Hua, Yunpeng
    Wang, Shutong
    Wang, Ting
    Dai, Shengjie
    Zhang, Shuhao
    Xie, Bingying
    Wu, Yinghao
    Hao, Chunyi
    CLINICAL CANCER RESEARCH, 2024, 30 (14) : 2937 - 2944
  • [39] Randomized multicenter phase II trial of two different schedules of capecitabine plus oxaliplatin as first-line treatment in advanced colorectal cancer
    Scheithauer, W
    Kornek, GV
    Raderer, M
    Schüll, B
    Schmid, K
    Kovats, E
    Schneeweiss, B
    Lang, F
    Lenauer, A
    Depisch, D
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (07) : 1307 - 1312
  • [40] Gemcitabine plus vinorelbine as first-line chemotherapy in advanced nonsmall cell lung carcinoma a Phase II trial
    Bajetta, E
    Stani, SC
    De Candis, D
    Bidoli, P
    Mariani, L
    Zilembo, N
    Pozzi, P
    Procopio, G
    CANCER, 2000, 89 (04) : 763 - 768
12345